ClinicalTrials.Veeva

Menu

The Effects of Continuous Positive Airway Pressure (CPAP) on Sympathetic Activity in Different Sites of Activation

U

University of Sao Paulo

Status and phase

Unknown
Phase 3

Conditions

Catecholamines
Blood Pressure Monitoring, Ambulatory
Sympathetic Nerve Activity
Exercise Test
Radionuclide Imaging (MIBG Scintigraphy)

Treatments

Device: CPAP

Study type

Interventional

Funder types

Other

Identifiers

NCT01336335
Sympathetic activity and OSA

Details and patient eligibility

About

Recent evidences suggest that obstructive sleep apnea (OSA) can contribute to cardiovascular disease even in the absence of hypertension. However, there are few data regarding the impact of OSA on the sympathetic system in apparently normotensive patients with OSA as well as the impact of treatment with continuous positive airway pressure in different sites of activation (heart, peripheral nerves and circulating catecholamines)

Enrollment

20 estimated patients

Sex

Male

Ages

30 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Severe OSA males

Exclusion criteria

  • Smoking

    • Sustained Hypertension
    • Heart failure
    • Diabetes
    • Renal diseases
    • Under use of any medication
    • Under treatment for OSA

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

20 participants in 2 patient groups

CPAP
Experimental group
Description:
OSA treatment with CPAP
Treatment:
Device: CPAP
control
No Intervention group
Description:
no intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems